Technological Advancements and Rising Cardiovascular Disease Prevalence Drive Growth in the Transcatheter Aortic Valve Replacement (TAVR) Market

Transcatheter aortic valve replacement market size was valued at $6.8 billion in 2024 and is projected to reach $12.6 billion by 2035, growing at a CAGR of 5.9% during the forecast period (2025–2035). Technological advancements in transcatheter aortic valve replacement (TAVR) devices are enhancing procedural safety, precision, and patient outcomes. Innovations such as next-generation valves, improved delivery systems, and minimally invasive techniques are expanding the adoption of TAVR across hospitals and cardiac care centers.

Browse the full report description of “Transcatheter Aortic Valve Replacement Market Size, Share & Trends Analysis Report by Product (Balloon-expandable valves, Self-expanding valves, and Mechanically-expanded valves) by Procedure (Transfemoral (TF), Transapical (TA), Transaortic (TAo), and Others) and by End User (Hospitals, Ambulatory Surgical Centers, and Others) Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/transcatheter-aortic-valve-replacement-market

Rising prevalence of cardiovascular diseases, particularly aortic stenosis among the aging population, is further driving demand for TAVR procedures. Favorable regulatory approvals and reimbursement policies are supporting wider adoption, making TAVR a preferred alternative to traditional open-heart surgery and contributing to sustained market growth.

Real-Life Developments Highlight the Growing Importance of Transcatheter Aortic Valve Replacement (TAVR)

• 2025: The American Heart Association (AHA) reported that aortic stenosis affects nearly 5% of adults aged 75 and above in the U.S., emphasizing the increasing need for minimally invasive TAVR procedures to improve patient outcomes and reduce surgical risks.
• 2024: The Centers for Medicare & Medicaid Services (CMS) reported that favourable reimbursement policies and coverage for TAVR procedures have driven wider adoption across cardiac care centers, improving accessibility for high-risk and ageing populations.
• 2024: According to the U.S. Food and Drug Administration (FDA), approvals of next-generation transcatheter valves and delivery systems have expanded the eligible patient population, enabling safer and more effective procedures for intermediate- and low-risk patients.

Technological Innovation and Market Expansion in TAVR

The TAVR market is growing rapidly due to next-generation valves, improved delivery systems, and minimally invasive techniques. Manufacturers are investing in R&D to enhance safety and patient outcomes, while regulatory approvals and favourable reimbursement policies are driving wider adoption across hospitals and cardiac care centers, supporting sustained market growth.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
• Product
• Procedure
• End User

• Competitive Landscape – Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic Plc and JenaValve Technology Inc.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Transcatheter Aortic Valve Replacement (TAVR) Market Report Segment

By Product

• Balloon-expandable valves
• Self-expanding valves
• Mechanically-expanded valves

By Procedure

• Transfemoral (TF)
• Transapical (TA)
• Transaortic (TAo)
• Others (Trans-subclavian, Trans-axillary, and Transcarotid)

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

Global Transcatheter Aortic Valve Replacement Market (TAVR) Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/transcatheter-aortic-valve-replacement-market